Ensysce Biosciences | D:發行公告
02/21 11:42 (美東)
Ensysce Biosciences | SC 13G/A:超過5%持股股東披露文件(修正)-Lincoln Park Capital Fund, LLC(3.792%),Lincoln Park Capital, LLC(3.792%)等
02/14 16:39 (美東)
Ensysce Biosciences | SC 13D/A:超過5%持股股東披露文件(修正)-Bob G. Gower(5.7%)
2023/07/17 18:15 (美東)
Ensysce Biosciences | 4:持股變動聲明-董事 GOWER BOB G
2023/03/06 16:33 (美東)
Ensysce Biosciences | 4:持股變動聲明-董事 GOWER BOB G
2023/03/02 15:45 (美東)
Ensysce Biosciences | D:發行公告
2023/03/01 10:33 (美東)
Ensysce Biosciences | SC 13G/A:超過5%持股股東披露文件(修正)-HG Vora Capital Management, LLC(2.1%)
2023/02/14 17:21 (美東)
Ensysce Biosciences | SC 13G/A:超過5%持股股東披露文件(修正)-CVI Investments, Inc.(4.9%),Heights Capital Management, Inc.(4.9%)
2023/02/14 11:20 (美東)
Ensysce Biosciences | SC 13G:超過5%持股股東披露文件-Lincoln Park Capital Fund, LLC(9.99%),Lincoln Park Capital, LLC(9.99%)等
2023/02/06 18:34 (美東)
Ensysce Biosciences | 4:持股變動聲明
2023/02/01 18:06 (美東)
Ensysce Biosciences | SC 13G:超過5%持股股東披露文件-CVI Investments, Inc.(7.8%),Heights Capital Management, Inc.(7.8%)
2022/12/16 10:24 (美東)
Ensysce Biosciences | D:發行公告
2022/07/08 17:30 (美東)
Ensysce Biosciences | SC 13D/A:超過5%持股股東披露文件(修正)-Matthews Lane Capital Partners LLC(7.9%),Daniel B. Silvers(7.9%)等
2022/07/07 09:08 (美東)
Ensysce Biosciences | 4:持股變動聲明
2022/06/27 17:47 (美東)
Ensysce Biosciences | 4:持股變動聲明
2022/06/27 17:44 (美東)
Ensysce Biosciences | 4:持股變動聲明
2022/06/27 17:41 (美東)
Ensysce Biosciences | 4:持股變動聲明
2022/06/27 17:40 (美東)
Ensysce Biosciences | 4:持股變動聲明
2022/06/27 17:38 (美東)
Ensysce Biosciences | 4:持股變動聲明
2022/06/27 17:38 (美東)
Ensysce Biosciences | 4:持股變動聲明
2022/06/27 17:35 (美東)
暫無數據
暫無數據